$47.53 -0.44 (-0.92%)
11/20/2009 3:59 PM

Smith & Nephew plc (ADR) (SNN)

CAPS Rating: 3 out of 5

The Company is a global business engaged in the development, manufacture and marketing of medical devices in the sectors of orthopaedic reconstruction, orthopaedic trauma and clinical therapies, endoscopy and advanced wound management.

Current Price $47.53 Mkt Cap $9.03B
Open $47.19 P/E Ratio 19.58
Prev. Close $47.97 Div. (Yield) 0.68 (1.40%)
Daily Range $47.17 - $47.66 Volume 27,732
52-Wk Range $30.01 - $48.95 Avg. Daily Vol. 74,000

SNN News and Commentary

Caps

How do you think SNN will perform vs the S&P 500?

Add Stock to Watchlist

All Members

92 Outperform
12 Underperform
 

All-Star Members

27 Outperform
3 Underperform
 

Wall Street

5 Outperform
1 Underperform
 

Top SNN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

nbpt100 (32.82)
Submitted July 29, 2008

Yes SNN will outperform the S&P 500 but don't expect huge returns. On the other hand the downward potential is not that much. It is a good investment based on the risk return ratio. This is a conservative company with a 1% dividend. Most of their… More

0 Comments | Reply | Report this Post

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

SNN VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about SNN.

Recs

0
Member Avatar sk8jeff1 (86.80) Submitted: 5/23/2009 9:53:06 AM : Outperform Start Price: $35.59 SNN Score: +8.43

Smith and Nephew is a large and safe company. SNN is near a 52 week low. Nothing about SNN itself has caused this drop in stock price. The costs of lending, oil prices and the generally poor economy have caused this stock to drop. SNN has a couple of new products in the final stages of development that will be used by orthopedic surgeons within the next year.SNN is widely regarded in the medical community for making safe, reliable and innovative products. They consult with and are counseled by physicians in Boston when making these products. There is no reason to believe their new products will not be just as successful as their past products. Get this stock near its 52 week low. It will pay you dividends and the price will grow.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar ipfmanager (98.28) Submitted: 2/25/2009 3:52:34 PM : Outperform Start Price: $32.62 SNN Score: +12.50

I'm the top scorer on this? Sheesh....

Let's see... Check my myl pitch-similar line of reasoning. Plus it's an adr for all those anti-americans out there. I actually like Striker or Zimmer better.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar ddberg (97.74) Submitted: 1/28/2009 11:07:43 AM : Outperform Start Price: $35.24 SNN Score: +6.33

Aging population that's living longer, exponential growth in orthopedic procedures, and a strong presence in those operating rooms.

Report this Post 0 Comments | Reply | Permalink
View All 15 Pitches »

Leaderboard

Find the members with the highest scoring picks in SNN.

Score Leader

healthcarevalue

healthcarevalue (95.03) Score: +27.08

Bought this stock in my CAPS at a price/earnings around 13, and sold it at a price/earnings around 27. It's still a great company with good products and reasonable price, but the p/e is too high for my blood.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
ROXYMUSIC1 88.08 12/7/2006 Outperform 3M $45.80 +3.78% -18.24% +22.02 1 Comment
Doughboy49 82.34 12/8/2006 Outperform 1Y $45.75 +3.88% -17.68% +21.57
Chateau33 96.32 10/16/2006 5/28/2008 Outperform 3Y $44.66 +6.44% -15.06% +21.50
danhbailey 27.70 10/17/2006 Outperform 3Y $44.58 +6.62% -14.81% +21.43
JIAN007 < 20 11/29/2006 Outperform 3Y $45.66 +4.10% -17.23% +21.33
TMcLeman 52.97 10/5/2006 Outperform 3W $44.28 +7.34% -13.89% +21.24
Fuma102 93.25 11/24/2006 Outperform 5Y $45.72 +3.95% -16.88% +20.83 1 Comment
yeraz 86.10 8/17/2009 Outperform 5Y $38.12 +24.69% +11.23% +13.45
ozarksmart 71.96 12/26/2006 Outperform 3M $49.78 -4.51% -17.51% +13.00
ipfmanager 98.28 1/26/2009 Outperform NS $32.62 +45.72% +33.22% +12.50 1 Comment
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackWachovia < 20 3/9/2009 Underperform NS $30.35 +56.62% +63.88% +7.27
TrackCitigroup < 20 2/18/2009 Outperform NS $37.61 +26.39% +39.57% -13.18
TrackCreditSuiss 90.95 1/26/2009 Outperform NS $32.62 +45.72% +33.22% +12.50
TrackPiperJaff 78.45 7/23/2008 Outperform NS $56.02 -15.16% -11.79% -3.37
TrackUBS 88.39 6/18/2008 Outperform NS $56.66 -24.73% -21.84% -2.89 10/7/2009 @ $42.65
TrackJPMorgan 73.67 5/13/2008 Underperform NS $53.03 -31.23% -36.34% -5.11 1/9/2009 @ $36.47
TrackLeerinkSwan 83.04 5/2/2008 Outperform NS $56.60 -3.43% -2.39% -1.04 6/3/2008 @ $54.66
TrackWachovia < 20 4/30/2008 Outperform NS $63.73 -42.90% -34.02% -8.87 1/7/2009 @ $36.39
TrackCowenandCo 69.87 1/18/2008 Outperform NS $60.92 -7.41% -6.97% -0.44 7/22/2008 @ $56.41
TrackBearStearns 81.70 11/13/2007 Outperform NS $58.60 -18.89% -21.13% +2.25
TrackJimCramer 36.31 9/5/2006 Outperform 3W $42.67 +11.39% -11.45% +22.83
TrackJimCramer 36.31 8/8/2006 Underperform 3W $41.57 +6.62% +3.29% -3.33 9/5/2006 @ $44.32

Featured Broker Partners